NEW YORK—Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as it works to double its sales in the country by the end of the decade, Bayer’s top U.S. pharmaceutical executive told Reuters. Sebastian Guth, president of Bayer’s pharmaceuticals business in the Americas, also said in an…

Pharmaceutical manufacturer Bayer Corporation and its related entities are to pay $40 million to resolve two whistleblower lawsuits filed by a former employee. The lawsuits were filed by Laurie Simpson who used to work in Bayer’s marketing department. They are related to false claims made by the company about three of its drugs: Trasylol, Avelox,…

FRANKFURT, Germany—Agriculture and pharmaceuticals company Bayer on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion euros ($13.21 billion), based…

The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87…

FRANKFURT—German drugmaker Bayer said it would invest around 2 billion euros ($2.23 billion) at pharmaceutical manufacturing sites over the next three years, mainly to bolster production of biotechnology drugs as well as cell and gene therapies. The sites to be upgraded include Berkeley, California, as well as Berlin, Leverkusen, and Bergkamen in Germany. In addition,…

Bayer AG reached an $80 million settlement with Ohio to resolve environmental damage allegedly caused by polychlorinated biphenyls, or PCBs, made by the company’s Monsanto business, the state attorney general said on Thursday. The funds from the German company, which did not admit liability, will be used for environmental cleanup, the attorney general said. Monsanto,…

FRANKFURT—Bayer on Monday struck a partnership deal with Mammoth Biosciences to develop therapeutic tools based on CRISPR/CAS9 gene editing as the German drug maker seeks to widen its cell and gene therapy development efforts. Unlisted U.S. biotech firm Mammoth will initially receive $40 million from Bayer plus potential milestone payments of more than $1 billion…

On Dec. 13, the Supreme Court asked the Solicitor General to offer the United States’ views on “Monsanto vs. Hardeman”—the latest move in what could be a landmark case for multibillion-dollar litigation linking the pesticide RoundUp to non-Hodgkin’s lymphoma, if the Supreme Court agrees to review the case. After a call for the views of…

A U.S. jury on Wednesday ordered Bayer AG to pay $62 million to students and others who say they were exposed to toxic chemicals made by the company’s predecessor, Monsanto Co, in a school building in Washington state. The verdict was the second against Bayer over polychlorinated biphenyls, or PCBs, at the Sky Valley Education…

MEXICO CITY—Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as “unscientific.” Reuters reported earlier in the day that regulator Cofepris rejected the corn…